Robert W. Baird Reaffirms $35.00 Target Price On HealthEquity Inc (NASDAQ:HQY), Reaffirms “Neutral” Rating

Share with your friends










Submit

Robert Baird Analyst Rating Change HealthEquity Inc NASDAQ:HQY

HealthEquity Inc (NASDAQ:HQY) Rating Reconfirmed

In analysts report issued to clients and investors on today, Robert W. Baird maintained their “Neutral” rating on HealthEquity Inc (NASDAQ:HQY)’s stock. The TP would indicate a potential upside of 0.84 % from company’s previous close.

NASDAQ:HQY is currently trading 2.79% higher at $34.81 as of 04:29 New York time. HealthEquity Inc’s stock is up 1.29% over the last 200 days. It has underperformed the S&P 500 Index, which has risen 4.94% over the same time period.

According to data compiled by Thomson Reuters, HealthEquity Inc (NASDAQ:HQY)’s stock is covered by 7 equity analysts across the Street, with 0 analysts giving it a Sell rating, 7 a Buy rating, while 1 consider it a Hold. The 12-month consensus target price for the stock is $30.86, which reflects an downside potential of 11.35% over the current price.

NASDAQ:HQY Price Chart & Trend

The stock price of HealthEquity Inc gained 1.29% over the last 200 days, and is in fragile up trend. In the last 50 and 100 days, HealthEquity Inc is up 18.77% and up 33.83%, respectively. Our stocks momentum model is shown on the price chart below.Robert W. Baird Reaffirms $35.00 Target Price On HealthEquity Inc (NASDAQ:HQY), Reaffirms "Neutral" Rating

Source: RightEdge Systems, Yahoo Split & Dividend Adjusted Data and OctaFinance Trading Models

HealthEquity Inc (NASDAQ:HQY) Profile

HealthEquity, Inc. provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. Its platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives and make educated investment choices to help in their tax-advantaged healthcare savings.

HealthEquity Inc (NASDAQ:HQY) traded up 2.79% on 7 September, hitting $34.81. A total of 464,007 shares of the company’s stock traded hands. This is up from average of 304,962 shares. HealthEquity Inc has a 52 week low of $15.80 and a 52 week high of $35.78. The company has a market cap of $2.04 billion and a P/E ratio of 104.68.

Get the latest HealthEquity Inc (NASDAQ:HQY) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

#metarobot=’index’##metadesc=’ HealthEquity Inc (NASDAQ:HQY) Rating Restated’##focuskw=’HealthEquity Inc (NASDAQ:HQY)’##newskw=’HealthEquity Inc (NASDAQ:HQY),Robert W. Baird Analyst Rating Change, HQY Stock Rating,NASDAQ:HQY Rating Maintain,HealthEquity Inc (NASDAQ:HQY) target price,HealthEquity Inc (NASDAQ:HQY) Robert W. Baird report,NASDAQ:HQY stock news,HQY stock risks upside,Robert W. Baird equity research coverage’##sitemap=’include’##skipsocial##stockticker=’NASDAQ:HQY’#

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.